Vanesa García‐Barberán

Author

Hospital Universitario Puerta de Hierro Majadahonda ORCID

Also Known As

Anna Ferrer, Garcia-Barberan, Vanesa, García-Barberán, Vanesa, Javier Silva, Judy Garber, Kathleen B.M. Claes, Lenka Foretova, Marike Gabrielson, Susan M. Gapstur, V García

200

Publications

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Puerta de Hierro Majadahonda Hospital Virgen de la Salud Instituto de Investigación Sanitaria del Hospital Clínico San Carlos Centro de Investigación Biomédica en Red de Cáncer Hospital Clínico San Carlos

About

Vanesa García‐Barberán is an author at Hospital Universitario Puerta de Hierro Majadahonda specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.1K
2	Cell Biology	8	8	636
3	Engineering	1	1	14
4	Health Sciences	1	1	214
5	Natural Sciences	1	1	96

Vanesa García‐Barberán

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Cancer‐associated fibroblast and <scp>M</scp>2 macrophage markers together predict outcome in colorectal cancer patients Mercedes Herrera, Alberto Herrera, Gemma Domínguez, Cancer Science ImmunologyPathologyCancer BiologyTumor BiologyTumor Immunity	2013	266
Deregulated expression of miR‐106a predicts survival in human colon cancer patients Raquel Díaz, Javier Silva, Yolanda Lorenzo, Genes Chromosomes and Cancer	2008	229
Promoter methylation of the <i>PTEN</i> gene is a common molecular change in breast cancer Javier Silva, Cristina Peña, Vanesa García‐Barberán, Genes Chromosomes and Cancer	2004	222
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial J. Guigay, Anne Aupérin, Jérôme Fayette, The Lancet Oncology Gortec 2014-01 TpextremeNeoadjuvant TherapyMedicineCisplatin Versus PlatinumHead And Neck Cancer	2021	214
E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations Cristina Peña, Javier Silva, Vanesa García‐Barberán, Human Molecular Genetics	2005	188
Functional Heterogeneity of Cancer-Associated Fibroblasts from Human Colon Tumors Shows Specific Prognostic Gene Expression Signature Mercedes Herrera, Abul Bashar Mir Md. Khademul Islam, Alberto Herrera, Clinical Cancer Research	2013	170
Different exosome cargo from plasma/bronchoalveolar lavage in non‐small‐cell lung cancer Marta Rodríguez, Javier Silva, Ana López‐Alfonso, Genes Chromosomes and Cancer	2014	159
The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E‐cadherin and vitamin D receptor in human colon carcinomas Cristina Peña, Vanesa García‐Barberán, Javier Silva, International Journal of Cancer	2006	142
ΔTAp73 Upregulation Correlates With Poor Prognosis in Human Tumors: Putative In Vivo Network Involving p73 Isoforms, p53, and E2F-1 Gemma Domínguez, José Manuel Pacheco García, Cristina Peña, Journal of Clinical Oncology	2005	110
Tumor-derived exosomes are enriched in ΔNp73, which promotes oncogenic potential in acceptor cells and correlates with patient survival Beatriz Soldevilla, Marta Rodríguez, Coral San Millán, Human Molecular Genetics Tumor-derived ExosomesExosomesEpigenetic RegulationMedicineNatural Sciences	2013	96

Page 1